121 related articles for article (PubMed ID: 3038401)
21. Centrally administered inhibitors of the generation and action of angiotensin II do not attenuate the increase in ACTH secretion produced by ether stress in rats.
Buckner FS; Chen FN; Wade CE; Ganong WF
Neuroendocrinology; 1986; 42(2):97-101. PubMed ID: 3005899
[TBL] [Abstract][Full Text] [Related]
22. Greater blood pressure-lowering effect of the renin inhibitor EMD 58265 than an angiotensin-converting enzyme inhibitor in two-kidney one-clip Goldblatt rabbit.
Zimmerman BG
Clin Exp Pharmacol Physiol; 2000; 27(5-6):370-7. PubMed ID: 10831238
[TBL] [Abstract][Full Text] [Related]
23. Effects of angiotensin I converting enzyme inhibition and calcium channel blockade on plasma levels of active and inactive renin in conscious rabbits.
Eisen V; Munday MR; Slater JD
Biochem Pharmacol; 1987 Jul; 36(14):2331-5. PubMed ID: 2440439
[TBL] [Abstract][Full Text] [Related]
24. Kinin contribution to renal vasodilator effect of captopril in rabbit.
Hajj-ali AF; Zimmerman BG
Hypertension; 1991 Apr; 17(4):504-9. PubMed ID: 1849501
[TBL] [Abstract][Full Text] [Related]
25. Regional haemodynamic effects of captopril, enalaprilat and lisinopril in conscious water-replete and water-deprived Brattleboro rats.
Muller AF; Gardiner SM; Compton AM; Bennett T
Clin Sci (Lond); 1990 Oct; 79(4):393-401. PubMed ID: 2171862
[TBL] [Abstract][Full Text] [Related]
26. Renal hemodynamic effects of nonhypotensive doses of angiotensin-converting enzyme inhibitors in hypertension and heart failure rats.
Nelissen-Vrancken HJ; Struijker-Boudier HA; Smits JF
J Cardiovasc Pharmacol; 1992 Feb; 19(2):163-8. PubMed ID: 1376783
[TBL] [Abstract][Full Text] [Related]
27. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
[TBL] [Abstract][Full Text] [Related]
28. An overview of the clinical pharmacology of enalapril.
Davies RO; Gomez HJ; Irvin JD; Walker JF
Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):215S-229S. PubMed ID: 6099737
[TBL] [Abstract][Full Text] [Related]
29. Factors affecting the regional haemodynamic responses to glyceryl trinitrate and molsidomine in conscious rats.
Phillips K; Gardiner SM; Kemp PA; Bennett T
Br J Pharmacol; 1991 Sep; 104(1):151-8. PubMed ID: 1786509
[TBL] [Abstract][Full Text] [Related]
30. Effects of acute angiotensin converting enzyme inhibition on renal blood flow in patients with stable congestive heart failure.
Le Jemtel TH; Maskin CS; Chadwick B
Am J Med Sci; 1986 Sep; 292(3):123-7. PubMed ID: 3019136
[TBL] [Abstract][Full Text] [Related]
31. Attenuation of pressor responses to intracerebroventricular angiotensin I by angiotensin converting enzyme inhibitors and their effects on systemic blood pressure in conscious rats.
Baum T; Becker FT; Sybertz EJ
Life Sci; 1983 Mar; 32(12):1297-303. PubMed ID: 6300578
[TBL] [Abstract][Full Text] [Related]
32. Comparative study of an angiotensin-II analog and a converting enzyme inhibitor.
Fagard RH; Amery AK; Lijnen PJ; Reybrouck TM
Kidney Int; 1980 May; 17(5):647-53. PubMed ID: 6249956
[TBL] [Abstract][Full Text] [Related]
33. Studies on mechanisms of antinephritic action of SA-446 an angiotensin I converting enzyme inhibitor (1). A comparison with actions of spironolactone, kallidinogenase and saralasin.
Suzuki Y; Ito M; Saito N
Jpn J Pharmacol; 1986 Dec; 42(4):465-75. PubMed ID: 3027437
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin II and noradrenergic transmission in the pithed rat.
Majewski H
J Cardiovasc Pharmacol; 1989 Oct; 14(4):622-30. PubMed ID: 2478776
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin-converting enzyme inhibition reduces neuroblastoma cell growth rate.
Chen L; Re RN; Prakash O; Mondal D
Proc Soc Exp Biol Med; 1991 Mar; 196(3):280-3. PubMed ID: 1998005
[TBL] [Abstract][Full Text] [Related]
36. Effects of angiotensin I converting enzyme inhibitors on the renal excretory function, hemodynamics and renin release in isolated perfused rat kidney.
Ogihara T; Yoshizawa M; Yasui T; Nakane H; Nakane Y; Saruta T
Jpn Heart J; 1983 Nov; 24(6):975-83. PubMed ID: 6323782
[TBL] [Abstract][Full Text] [Related]
37. Vasodepressor role of endogenous bradykinin assessed by a bradykinin antagonist.
Benetos A; Gavras H; Stewart JM; Vavrek RJ; Hatinoglou S; Gavras I
Hypertension; 1986 Nov; 8(11):971-4. PubMed ID: 3021624
[TBL] [Abstract][Full Text] [Related]
38. Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition.
Clappison BH; Anderson WP; Johnston CI
Kidney Int; 1981 Nov; 20(5):615-20. PubMed ID: 6283229
[TBL] [Abstract][Full Text] [Related]
39. ACE inhibition and pressor responsiveness to norepinephrine in hypertensive patients.
Malini PL; Strocchi E; Valtancoli G; Ambrosioni E
J Clin Pharmacol; 1990 May; 30(5):422-4. PubMed ID: 2161435
[TBL] [Abstract][Full Text] [Related]
40. Effect of angiotensin-converting enzyme inhibition on renal norepinephrine spillover rate and baroreflex responses in conscious rabbits.
Noshiro T; Way D; McGrath BP
Clin Exp Pharmacol Physiol; 1991 May; 18(5):375-8. PubMed ID: 1648463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
